ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.3% · netto nieuwe posities -3.7% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 181 | +6 | 1.06B | $267.14B | +9 | −4 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | n/a | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | n/a |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | n/a | n/a |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | n/a | n/a |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | n/a | 90.79M | $15.55B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 177.75M | +0.2% | $41.16B | 0.6% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (passief) | 145.98M | -1.0% | $33.80B | 0.6% | ▼ Trim | 2 | SEC ↗ ×23 |
| 3 | JPMorgan Chase ✦ | 113.07M | n/a | $26.18B | 0.8% | n/c | 1 | SEC ↗ ×46 |
| 4 | State Street Global Advisors ✦ (passief) | 79.82M | -0.2% | $18.48B | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 41.65M | n/a | $9.64B | 0.6% | n/c | 1 | SEC ↗ ×23 |
| 6 | Geode Capital Management ✦ (passief) | 40.44M | +3.2% | $9.33B | 0.6% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Fidelity (FMR) ✦ | 21.04M | +0.2% | $4.87B | 0.3% | ▲ Add | 2 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 13.40M | n/a | $3.10B | 0.4% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 10.60M | +17.0% | $2.45B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 10.54M | +457.4% | $2.44B | 0.4% | ▲ Add | 6 | SEC ↗ ×9 |
| 11 | Capital World Investors ✦ | 6.34M | -2.1% | $1.47B | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 3.11M | -4.5% | $719.03M | 0.6% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 2.02M | -17.6% | $466.72M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 1.84M | +14.0% | $427.14M | 0.7% | ▲ Add | 6 | SEC ↗ |
| 15 | Marshall Wace ✦ | 1.28M | -7.4% | $295.72M | 0.3% | ▼ Trim | 6 | SEC ↗ ×3 |
| 16 | D. E. Shaw & Co. ✦ | 1.12M | -27.4% | $259.13M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Renaissance Technologies ✦ | 928.07K | -52.7% | $214.89M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 926.84K | +55.0% | $209.65M | 0.1% | ▲ Add | 6 | SEC ↗ ×7 |
| 19 | Point72 Asset Management ✦ | 359.44K | +6799.1% | $83.23M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 275.85K | -2.7% | $63.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 260.69K | -56.4% | $60.36M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 184.69K | -41.7% | $42.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 163.18K | -36.2% | $37.78M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 48.47K | +31.8% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 15.27K | -3.1% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | Dodge & Cox ✦ | 10.47K | 0.0% | $2.42M | 0.0% | Held | 6 | SEC ↗ |
| 27 | Harris Associates (Oakmark) ✦ | 3.16K | 0.0% | $732,361 | 0.0% | Held | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $4.29B | was 0.5% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 4,042 houders, 1.24B aandelen, $260.03B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 32.71K aand · $8.18M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie